Amedica releases Valeo II TL silicon nitride interbody fusion devices Redesigned Transforaminal Lumbar Device Provides Amedica with Broader Interbody Fusion Device Market Opportunities Amedica Corporation , a industrial biomaterial company centered on silicon nitride ceramics because a material system to develop, produce and sell novel medical gadgets, is very happy to announce the release of the second generation silicon nitride transforaminal lumbar interbody fusion device.4 billion spinal interbody fusion device market. We remain dedicated to bringing brand-new and innovative solutions to the market that we believe offer distinct advantages to enhance the efficacy of spinal fusion techniques, resulting in enhanced patient treatment..Medical indications include uncontrolled movements, depression and dementia, but these symptoms usually do not appear before afflicted reach their 30s or 40s usually. Despite major strides ahead in understanding the condition in recent years, there happens to be no cure. The disease starts when the huntingtin proteins falls off HIP1. The vacancy allows another proteins, HIPPI, to after that bind to HIP1. The complex of HIPPI and HIP1 is in charge of activating other proteins that cause the death of cells. The loss of huge amounts of nerve cells qualified prospects to a lack of motor function, and brain function eventually, too.